Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Immunogen Inc (IMGN)  
$31.23 0.00 (0.00%) as of 4:30 Thu 2/8


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 264,900,000
Market Cap: 8.27(B)
Last Volume: 49,305,461 Avg Vol: 7,165,494
52 Week Range: $12.46 - $31.23
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:

    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  606
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   ImmunoGen is a clinical-stage biotechnology company focused on developing the antibody-drug conjugates (ADCs). Co.'s main program is mirvetuximab, an ADC targeting folate receptor alpha, a cell-surface protein overexpressed in a number of epithelial tumors, including ovarian, endometrial, and non-small-cell lung cancers. Pivekimab sunirine is an ADC comprised of an antibody designed to target CD123 with site-specific conjugation to a DNA-alkylating payload of the IGN (indolinobenzodiazepine pseudodimer) class. Co.'s pipeline program, IMGC936, is an ADC that is designed to target ADAM9, an enzyme overexpressed in a range of solid tumors and implicated in tumor progression and metastasis.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 233,563 4,785,085 4,785,085
Total Sell Value $0 $6,909,682 $86,338,289 $86,338,289
Total People Sold 0 4 5 5
Total Sell Transactions 0 6 26 26
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 453
  Page 11 of 19  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Junius Daniel M Chief Executive Officer   •       •      –    2015-04-02 4 OE $5.74 $149,998 D/D 26,132 124,189     -
   Lambert John Executive Vice President   •       –      –    2015-04-01 4 AS $8.74 $87,384 D/D (10,000) 106,857     -
   Lambert John Executive Vice President   •       –      –    2015-04-01 4 OE $5.35 $53,500 D/D 10,000 116,857     -
   Gregory Richard J. Executive VP & CSOOfficer   •       –      –    2015-01-05 3 IO $0.00 $0 D/D 0 25,000     -
   Morris Charles Q Executive VP & CDO   •       –      –    2014-11-28 4 AS $10.40 $54,496 D/D (5,240) 32,260     -
   Junius Daniel M Chief Executive Officer   •       •      –    2014-09-19 4 OE $5.74 $99,997 D/D 17,421 98,057     -
   Barrows Craig Vice-President,General Counsel   •       –      –    2014-05-05 4 OE $3.30 $49,500 D/D 15,000 21,100     -
   Junius Daniel M Chief Executive Officer   •       •      –    2014-03-17 4 S $16.40 $246,000 D/D (15,000) 80,636     -
   Junius Daniel M Chief Executive Officer   •       •      –    2014-03-17 4 OE $5.74 $86,100 D/D 15,000 95,636     -
   Morris Charles Q Executive VP & CDO   •       –      –    2014-02-26 4 AS $17.35 $120,333 D/D (6,936) 37,500     -
   Morris Charles Q Executive VP & CDO   •       –      –    2014-02-26 4 OE $11.93 $82,746 D/D 6,936 44,436     -
   Morris Charles Q Executive VP & CDO   •       –      –    2014-02-20 4 AS $17.10 $233,737 D/D (13,672) 37,500     -
   Morris Charles Q Executive VP & CDO   •       –      –    2014-02-20 4 OE $11.93 $163,107 D/D 13,672 51,172     -
   Junius Daniel M Chief Executive Officer   •       •      –    2014-02-18 4 S $16.26 $243,923 D/D (15,000) 80,636     -
   Junius Daniel M Chief Executive Officer   •       •      –    2014-02-18 4 OE $5.74 $86,100 D/D 15,000 95,636     -
   Lambert John Executive Vice President   •       –      –    2014-02-03 4 AS $14.90 $65,188 D/D (4,375) 106,857     -
   Lambert John Executive Vice President   •       –      –    2014-02-03 4 OE $6.27 $27,431 D/D 4,375 111,232     -
   Morris Charles Q Executive VP & CDO   •       –      –    2014-01-22 4 AS $17.00 $27,257 D/D (1,603) 37,500     -
   Morris Charles Q Executive VP & CDO   •       –      –    2014-01-22 4 OE $11.93 $19,124 D/D 1,603 39,103     -
   Morris Charles Q Executive VP & CDO   •       –      –    2014-01-21 4 AS $17.00 $94,095 D/D (5,535) 37,500     -
   Morris Charles Q Executive VP & CDO   •       –      –    2014-01-21 4 OE $11.93 $66,033 D/D 5,535 43,035     -
   Wingrove Theresa VP of Regulatory Affairs   •       –      –    2014-01-10 4 AS $15.04 $93,994 D/D (6,250) 0     -
   Wingrove Theresa VP of Regulatory Affairs   •       –      –    2014-01-10 4 OE $9.85 $61,563 D/D 6,250 6,250     -
   Lambert John Executive Vice President   •       –      –    2014-01-02 4 AS $14.53 $63,547 D/D (4,375) 106,857     -
   Lambert John Executive Vice President   •       –      –    2014-01-02 4 OE $6.27 $27,431 D/D 4,375 111,232     -

  453 Records found
  Previous  10  11  12  13  14  15  16  17  18  19   
  Page 11 of 19
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed